EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Strategies and Challenges in Coding Ambiguous Information Using MedDRA®: An Exploration Among Norwegian Pharmacovigilance Officers

Tahmineh Garmann, Hilde Samdal, Daniele Sartori, David Jahanlu, Fredrik Andersen, Elena Rocca

Drug Safety · 2025

DOI: 10.1007/s40264-025-01573-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Safety, 2025. Verfasst von Tahmineh Garmann und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, Institute for Natural Science and Health, Oslo Metropolitan University, Postboks 4, St.Olavs plass, 0130, Oslo, Norway. Hauptthemen laut MEDLINE: Pharmacovigilance, Adverse Drug Reaction Reporting Systems, Drug-Related Side Effects and Adverse Reactions, Clinical Coding. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: OsloMet - Oslo Metropolitan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The Medical Dictionary for Regulatory Activities (MedDRA®) is an international standardized medical terminology used to code various types of medical information, including safety reports of suspected adverse reactions to medicines. Quantitative studies have highlighted varying levels of coding inconsistency across MedDRA®-relevant platforms, though the possible grounds of such inconsistency remain unclear. OBJECTIVE: We explored the reasoning and strategies employed by pharmacovigilance officers when coding selected ambiguous adverse events to MedDRA®, categorized the types of coding inconsistencies, and explored sources of the inconsistencies. METHODS: Pharmacovigilance officers from the Norwegian public health sector were invited to participate in a survey-based, cross-sectional study followed by focus group interviews. The survey consisted of 11 coding tasks, with varying degrees of ambiguity, purposively sampled from the Norwegian pharmacovigilance registry. Participants selected the appropriate MedDRA® terms and graded the difficulty level of each task on a scale from 1 (least difficult) to 4 (most difficult). Terms selected by participants were compared with a Standard Term Selection (STS), agreed upon by the authors in consultation with a MedDRA® trainer. Inconsistencies with the STS were classified as omission (missing term), substitution (extra term selected in the presence of an omission), and addition (extra term selected and none omitted). In focus groups, participants discussed challenges in the coding tasks and the strategies they used to overcome them. Interview transcripts were analyzed using thematic analysis. RESULTS: In total, 26 coders (79% of the eligible population) completed the survey. Of the survey answers, 36% were identical to the STS; answers consistent with the STS varied across the specific coding tasks and did not align with the perceived difficulty of the tasks. The most common inconsistency (30% of the survey answers) arose from substituting one of multiple MedDRA® terms. Of the survey answers, 18% included omissions without substitutions, and 6% added unnecessary terms to the STS. Eight of the 26 coders (31%) participated in the focus group interviews. Focus group themes revealed that substitutions were explained by difficulties in translating lay language to medical terminology, finding accurate English translations for Norwegian medical terms, and fitting complex descriptions into MedDRA® terms. This was explained by themes related to ambiguity-resolution strategies. Themes explaining omissions included strategies for resolving ambiguity, contextual thinking, causal and pharmacological reasoning in the coding process, and information categorization. CONCLUSIONS: Tailored training programs and clear institutional guidelines are needed to target the sources of coding inconsistencies suggested by this study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacovigilanceAdverse Drug Reaction Reporting SystemsDrug-Related Side Effects and Adverse ReactionsClinical CodingHumansNorwayCross-Sectional StudiesFocus GroupsSurveys and QuestionnairesFemaleTerminology as TopicMaleAdult

Autor:innen und Institutionen

  • Faculty of Health Sciences, Institute for Natural Science and Health, Oslo Metropolitan University, Postboks 4, St.Olavs plass, 0130, Oslo, Norway.
  • Norwegian Medical Product Agency, Oslo, Norway.
  • Uppsala Monitoring Centre, Uppsala, Sweden.
  • Faculty of Health, Welfare and Organization, Østfold University College, Fredrikstad, Norway.
  • Faculty of Health Sciences, Institute for Natural Science and Health, Oslo Metropolitan University, Postboks 4, St.Olavs plass, 0130, Oslo, Norway. elena.rocca@oslomet.no.

Förderung

  • OsloMet - Oslo Metropolitan University

Zitieren

APA

Garmann, T., Samdal, H., Sartori, D., Jahanlu, D., Andersen, F., & Rocca, E. (2025). Strategies and Challenges in Coding Ambiguous Information Using MedDRA®: An Exploration Among Norwegian Pharmacovigilance Officers. Drug Safety. https://doi.org/10.1007/s40264-025-01573-2

Vancouver

Garmann T, Samdal H, Sartori D, Jahanlu D, Andersen F, Rocca E. Strategies and Challenges in Coding Ambiguous Information Using MedDRA®: An Exploration Among Norwegian Pharmacovigilance Officers. Drug Safety. 2025. doi:10.1007/s40264-025-01573-2

BibTeX
@article{Garmann2025,
  author = {Garmann, Tahmineh and Samdal, Hilde and Sartori, Daniele and Jahanlu, David and Andersen, Fredrik and Rocca, Elena},
  title = {Strategies and Challenges in Coding Ambiguous Information Using MedDRA®: An Exploration Among Norwegian Pharmacovigilance Officers},
  journal = {Drug Safety},
  year = {2025},
  doi = {10.1007/s40264-025-01573-2}
}
Kostenlos starten →